The AGENT™ Drug-Coated Balloon (DCB) makes reliable drug transfer more deliverable. AGENT is unlike other DCBs on the market. It builds on the proven balloon innovation and …

AGENT is the first and only U.S. coronary drug-coated balloon (DCB), introducing a new treatment option for patients with in-stent restenosis (ISR). AGENT is purposefully designed to …

Boston Scientific's Ranger Drug-Coated Balloon is built on the physician preferred Sterling™ 0.014”/0.018” balloon platform¹ with the lowest tip entry profile of any SFA DCB². For ease, …

The AGENTTM Paclitaxel-Coated Balloon Catheter (hereafter referred to as AGENT Drug-Coated Balloon (DCB), AGENT Balloon Catheter, or AGENT DCB) is a monorail, semi-compliant...

2023年10月25日 · This trial met the primary endpoint of target lesion failure 4 (TLF) at 12 months with the AGENT DCB demonstrating statistical superiority to uncoated balloon angioplasty …

2023年10月25日 · MARLBOROUGH, Mass. and SAN FRANCISCO, Oct. 25, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from …

MARLBOROUGH, Mass., March 1, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for …

October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT IDE clinical trial of the AGENT Drug-Coated Balloon (DCB).1 Primary …

2020年6月22日 · Drug-coated balloons (DCBs) are a novel treatment strategy for coronary artery disease based on the fast and homogenous transfer of antiproliferative drugs into the vessel …

Ranger is a low dose DCB with a uniquely formulated TransPax coating that results in highly efficient drug transfer. This enables extremely targeted drug delivery, achieving nearly 90% …